These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28459467)

  • 21. A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-κB.
    Gopalakrishnan R; Matta H; Chaudhary PM
    Clin Cancer Res; 2013 Sep; 19(18):5016-26. PubMed ID: 23881928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma.
    Wong JP; Stuhlmiller TJ; Giffin LC; Lin C; Bigi R; Zhao J; Zhang W; Bravo Cruz AG; Park SI; Earp HS; Dittmer DP; Frye SV; Wang X; Johnson GL; Damania B
    Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16541-16550. PubMed ID: 31346082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo anti-primary effusion lymphoma activities of fucoidan extracted from Cladosiphon okamuranus Tokida.
    Ishikawa C; Mori N
    Oncol Rep; 2017 Nov; 38(5):3197-3204. PubMed ID: 29048633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyrrolidinium fullerene induces apoptosis by activation of procaspase-9 via suppression of Akt in primary effusion lymphoma.
    Watanabe T; Nakamura S; Ono T; Ui S; Yagi S; Kagawa H; Watanabe H; Ohe T; Mashino T; Fujimuro M
    Biochem Biophys Res Commun; 2014 Aug; 451(1):93-100. PubMed ID: 25063029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma.
    Mohanty S; Kumar A; Das P; Sahu SK; Choudhuri T
    Apoptosis; 2017 Sep; 22(9):1098-1115. PubMed ID: 28653223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. YM155 induces apoptosis through proteasome-dependent degradation of MCL-1 in primary effusion lymphoma.
    Kojima Y; Hayakawa F; Morishita T; Sugimoto K; Minamikawa Y; Iwase M; Yamamoto H; Hirano D; Imoto N; Shimada K; Okada S; Kiyoi H
    Pharmacol Res; 2017 Jun; 120():242-251. PubMed ID: 28396094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic analysis of xCT-mediated regulatory network: Identification of novel targets against AIDS-associated lymphoma.
    Dai L; Cao Y; Chen Y; Kaleeba JA; Zabaleta J; Qin Z
    Oncotarget; 2015 May; 6(14):12710-22. PubMed ID: 25860939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-κB pathway.
    Goto H; Kariya R; Shimamoto M; Kudo E; Taura M; Katano H; Okada S
    Cancer Sci; 2012 Apr; 103(4):775-81. PubMed ID: 22320346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hippuristanol reduces the viability of primary effusion lymphoma cells both in vitro and in vivo.
    Ishikawa C; Tanaka J; Katano H; Senba M; Mori N
    Mar Drugs; 2013 Sep; 11(9):3410-24. PubMed ID: 24018901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
    Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
    Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and Kaposi's sarcoma.
    Roy D; Dittmer DP
    Am J Pathol; 2011 Oct; 179(4):2108-19. PubMed ID: 21819957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoring PU.1 induces apoptosis and modulates viral transactivation via interferon-stimulated genes in primary effusion lymphoma.
    Goto H; Kariya R; Kudo E; Okuno Y; Ueda K; Katano H; Okada S
    Oncogene; 2017 Sep; 36(37):5252-5262. PubMed ID: 28481873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity of the synthetic retinoid ST1926 on primary effusion lymphoma in vitro and in vivo models.
    Karam L; Houshaymi B; Abdel-Samad R; Jaafar M; Halloum I; Pisano C; Neipel F; Darwiche N; Abou Merhi R
    Oncol Rep; 2018 Feb; 39(2):721-730. PubMed ID: 29207182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pyridinium‑type fullerene derivative suppresses primary effusion lymphoma cell viability via the downregulation of the Wnt signaling pathway through the destabilization of β‑catenin.
    Kadota A; Moriguchi M; Watanabe T; Sekine Y; Nakamura S; Yasuno T; Ohe T; Mashino T; Fujimuro M
    Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35014678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma.
    Manzano M; Patil A; Waldrop A; Dave SS; Behdad A; Gottwein E
    Nat Commun; 2018 Aug; 9(1):3263. PubMed ID: 30111820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone; 3-AP): an inhibitor of ribonucleotide reductase with antineoplastic activity.
    Finch RA; Liu MC; Cory AH; Cory JG; Sartorelli AC
    Adv Enzyme Regul; 1999; 39():3-12. PubMed ID: 10470363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-alpha.
    Wu W; Rochford R; Toomey L; Harrington W; Feuer G
    Leuk Res; 2005 May; 29(5):545-55. PubMed ID: 15755507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The anti-malaria agent artesunate exhibits cytotoxic effects in primary effusion lymphoma.
    Ishikawa C; Mori N
    Invest New Drugs; 2021 Feb; 39(1):111-121. PubMed ID: 32885355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression.
    Dai L; Trillo-Tinoco J; Bai A; Chen Y; Bielawski J; Del Valle L; Smith CD; Ochoa AC; Qin Z; Parsons C
    Oncotarget; 2015 Sep; 6(27):24246-60. PubMed ID: 26327294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of tumor suppressor genes by exogenous dhC16-Cer contributes to its anti-cancer activity in primary effusion lymphoma.
    Cao Y; Qiao J; Lin Z; Zabaleta J; Dai L; Qin Z
    Oncotarget; 2017 Feb; 8(9):15220-15229. PubMed ID: 28146424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.